Desiree Luthman

Desiree Luthman has a diverse work experience spanning over several decades. Desiree is currently working as the Vice President at Egetis Therapeutics AB since January 2024. Prior to this, they held the position of Senior Vice President Regulatory Affairs at Passage Bio from October 2021 to January 2024. From June 2017 to September 2021, Desiree worked as the VP Regulatory Affairs at Verona Pharma. Desiree also served as the Senior Director Global Regulatory Affairs at Sanofi from February 2015 to May 2017. Before that, they held various roles at BMS, including Director of Global Regulatory Affairs, GRSS BMS from July 2013 to February 2015. Additionally, they worked as the Director of Global Regulatory Affairs at BMS from January 2013 to July 2013. Desiree also has experience at Celgene as the Director of EU Regulatory Affairs Inflammation & Immunology from May 2008 to January 2013, at Xytis Pharmaceuticals as the Head of Regulatory Affairs from October 2006 to April 2008, at AstraZeneca as the Global Director of Regulatory Affairs from February 1996 to September 2006, at Folktandvården General Dental Practice as a Dentist from August 1991 to February 1996, and at the University of Colorado Health Sciences Center as a Post Doctoral LabTech from April 1990 to June 1991.

Desiree Luthman attended Karolinska Institutet from 1983 to 1988 and obtained a DDS degree. No specific field of study was mentioned.